- Invest smart this year in the only HMRC approved Knowledge Intensive fund, this allows you to carry back EIS relief to 2019/20, or the benefit of investing in this current year, deadline April 1st (capital at risk, depending on individual circumstances )
- Two part investment focus of Access & Incubation, providing unique opportunities and reducing investment risk by being deeply involved.
- Aiming to build a diverse portfolio for investors with an initial Portfolio of 5-10 unquoted and/or AIM-listed companies.
Fund Size | Target £ 10m |
---|---|
Current AUM | £ 500k |
Expected Exit | 3-7 years |
Founder's Investment | Minimum 10% of every investment |
Closing Dates | 1st April 2021 |
- +History in grassroots science
We have a track record of nurturing and investing in emerging life science and tech companies – the o2h ventures team are leaders in the biotech community and have been involved as investors, holding various board/industry positions awe well as being engaged in grassroot scientific activity for over 20 years.
- +Evaluation
- +Access to scientific talents
- +Business model
EIS tax relief is very attractive for UK tax payers
You invest £50k
EIS gives you £15k tax relief from HMRC
EIS gives you £25k tax relief from HMRC
Investment now worth £100k
£50k profit
income tax relief £15k
performance incentive £10k
net profit £55k
Investment still worth £50k
£0 profit
income tax relief £15k
performance incentive £0
net profit £15k
Investment now worth £0
£50k loss
income tax relief £15k
loss relief £15,750 *
performance incentive £0
capital loss £19,250
* Loss relief calculated on higher rate tax bracket Worked example is net of any fund fees
- o2h ventures – making waves in knowledge intensive and SEIS investing 21 December, 2020
- Knowledge intensive investing… a new investment era 9 December, 2020
- o2h ventures leads the funding into Cambridge University Biotech Spinout Spirea 7 December, 2020